Results 31 to 40 of about 115,511 (189)
Acta Medica Indonesiana, 2021 Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections.
Erni Juwita Nelwan +3 more
doaj +2 more sources
Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection [PDF]
Clinical Drug Investigation, 2022 Omadacycline, a first-in-class aminomethylcycline antibiotic, is approved in the USA as intravenous (IV) and/or oral therapy for treatment of adults with community-acquired bacterial pneumonia (CABP) or acute bacterial skin and skin structure infections (ABSSSI). Phase 1 and 3 studies indicate that omadacycline dose adjustments are not required for any
Ira M. Leviton, Maria Amodio-Groton
openaire +2 more sources
Infectious Diseases and Therapy, 2018 Introduction The prevalence of acute bacterial skin and skin structure infections (ABSSSIs) continues to increase. Bloodstream infection (BSI) is a severe secondary complication of ABSSSI.
Michael J. Rybak +6 more
doaj +1 more source
Columnaris disease in fish: a review with emphasis on bacterium-host interactions [PDF]
, 2013 Flavobacterium columnare (F. columnare) is the causative agent of columnaris disease. This bacterium affects both cultured and wild freshwater fish including many susceptible commercially important fish species. F. columnare infections may result in skin
Bossier, Peter +4 more
core +3 more sources
Early Endpoints for Acute Bacterial Skin and Skin Structure Infections [PDF]
Antimicrobial Agents and Chemotherapy, 2012 In this issue of the journal, [Friedland et al.][1] ([4][2]) present a retrospective analysis of the two CANVAS trials ([3][3]), employing the newer endpoints from the U.S. Food and Drug Administration (FDA) ([7][4]).
openaire +2 more sources
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
Antibiotics, 2021 Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved ...
Béla Kocsis +2 more
doaj +1 more source
Spirochetal Lipoproteins and Immune Evasion. [PDF]
, 2017 Spirochetes are a major threat to public health. However, the exact pathogenesis of spirochetal diseases remains unclear. Spirochetes express lipoproteins that often determine the cross talk between the host and spirochetes.
Boyadjian, Ani +2 more
core +1 more source
Journal of Global Antimicrobial Resistance, 2020 Objectives: The aim of this survey was to identify a set of actions aimed to improve the diagnosis and management of acute bacterial skin and skin-structure infections (ABSSSIs) and the implementation of some principles of antimicrobial stewardship (AMS)
Alex Soriano +3 more
doaj +1 more source
Pathogens, 2022 Atopic dermatitis (AD) is a condition with a complex and unclear aetiology. Possible causes of AD encompass alterations in the structure and function of the epidermal barrier, disturbances in the skin microbiome, immune factors, allergens, bacterial and ...
Danuta Nowicka +2 more
doaj +1 more source
Galectin-3. One molecule for an alphabet of diseases, from A to Z [PDF]
, 2018 Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix interactions, growth, proliferation, differentiation, and inflammation.
Bellotti, Carlo +8 more
core +2 more sources